These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 2663585)

  • 1. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
    G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
    Caponnetto S; Terrachini V; Canale C; Bruzzone F; Licciardello L; Marchetti GV
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S104-10. PubMed ID: 2483435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].
    Fonseca C; Gouveia R; Ceia F; Mota E; Coelho EM; Gil V; Riva E; Astorga MA; Gomes RS; Luís AS
    Rev Port Cardiol; 1992 Jun; 11(6):515-23. PubMed ID: 1503784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive inotropic effects of ibopamine in patients with congestive heart failure. A multicenter investigation.
    Caponnetto S; Allegro A; Bellotti G; Cataldi A; Salvemini M; Portioli I; Prati PL; Gambelli G; Boccanelli A; Zacharo E
    Arzneimittelforschung; 1986 Feb; 36(2A):386-90. PubMed ID: 3518725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
    Alicandri C; Fariello R; Boni E; Zaninelli A; Muiesan G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S77-82. PubMed ID: 2483444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.
    Cadel A; Brusoni B; Pirelli P; Osculati G; Rovati A; Fanciulli R; Carati L; Valagussa F
    Arzneimittelforschung; 1986 Feb; 36(2A):376-9. PubMed ID: 3707653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
    Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term efficacy of ibopamine in treating patients with severe heart failure: a multicenter investigation.
    Condorelli M; Bonaduce A; Montemurro A; Mattioli G; Cappello C; Caponnetto S; Terrachini V; Canale C; Varricchio M; Cacciapuoti F
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S83-92. PubMed ID: 2483445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
    Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.
    Sher D; Licciardello L; Ferrari V; Sirtori F; Cesana B
    Arzneimittelforschung; 1991 Apr; 41(4):402-9. PubMed ID: 1859514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L; Ibba GV; Castellaccio M; Dore L
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study between ibopamine and captopril in mild and moderate heart failure. A double-blind study].
    Arcensio SR; Barretto AC; Szambock F; Mady C; Arteaga E; da Luz PL; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1994 Nov; 63(5):409-13. PubMed ID: 7611921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A; Mussini A; Bramucci E
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure.
    Ferrari V; Sher D; Marchetti G
    Arzneimittelforschung; 1986 Feb; 36(2A):398-405. PubMed ID: 3707657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of ibopamine in long-term treatment of dilated cardiomyopathy. A clinical and instrumental evaluation.
    Benassi A; Modena MG; Mattioli G
    Arzneimittelforschung; 1986 Feb; 36(2A):390-4. PubMed ID: 3518726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Echocardiographic and polygraphic study of acute/effects of Ibopamine on cardiac performance].
    Ladelli L; Pezzano A; Sala G; Mangiavacchi M; Cadel A; Brusoni B
    G Ital Cardiol; 1983 Oct; 13(10):239-48. PubMed ID: 6667808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibopamine: long-term safety study in patients with congestive heart failure. The Italian Ibopamine Working Group.
    Riva E; Cavalli A; Abbondati G; Cedrini MC; Schleman M; Fuccella LM
    Int J Clin Pharmacol Res; 1989; 9(1):21-8. PubMed ID: 2707922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter study on the clinical efficacy of chronic ibopamine administration.
    Dei Cas L; Barilli AC; Metra M; Fracalossi C; Lomanto B; Santambrogio S; Pinca L; Longhini C; Cavicchi E; Maggi GC
    Arzneimittelforschung; 1986 Feb; 36(2A):383-5. PubMed ID: 3707655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L; Metra M; Nodari S; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.